Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
by
Dowsett, Mitch
, Hayes, Daniel F
, Braybrooke, Jeremy
, Pritchard, Kathleen I
, Bergh, Jonas
, Davies, Christina
, Gray, Richard
, Peto, Richard
, McGale, Paul
, Pan, Hongchao
, Taylor, Carolyn
in
Adult
/ Age
/ Aged
/ Breast cancer
/ Breast Neoplasms - drug therapy
/ Breast Neoplasms - mortality
/ Breast Neoplasms - pathology
/ Cancer and Oncology
/ Cancer och onkologi
/ Chemotherapy, Adjuvant
/ Clinical Medicine
/ Clinical outcomes
/ Clinical trials
/ Drug Administration Schedule
/ Endocrine therapy
/ Epidermal growth factor
/ ErbB-2 protein
/ Estrogen Antagonists - therapeutic use
/ Estrogen receptors
/ Female
/ Humans
/ Kaplan-Meier Estimate
/ Klinisk medicin
/ Lymphatic Metastasis
/ Lymphatic system
/ Medical and Health Sciences
/ Medical research
/ Medicin och hälsovetenskap
/ Middle Aged
/ Monoclonal antibodies
/ Neoplasm Grading
/ Neoplasm Metastasis
/ Neoplasm Recurrence, Local
/ Patients
/ Progesterone
/ Prognosis
/ Proportional Hazards Models
/ Receptors, Estrogen
/ Recurrence
/ Risk
/ Systematic review
/ Targeted cancer therapy
/ Trastuzumab
/ Womens health
2017
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
by
Dowsett, Mitch
, Hayes, Daniel F
, Braybrooke, Jeremy
, Pritchard, Kathleen I
, Bergh, Jonas
, Davies, Christina
, Gray, Richard
, Peto, Richard
, McGale, Paul
, Pan, Hongchao
, Taylor, Carolyn
in
Adult
/ Age
/ Aged
/ Breast cancer
/ Breast Neoplasms - drug therapy
/ Breast Neoplasms - mortality
/ Breast Neoplasms - pathology
/ Cancer and Oncology
/ Cancer och onkologi
/ Chemotherapy, Adjuvant
/ Clinical Medicine
/ Clinical outcomes
/ Clinical trials
/ Drug Administration Schedule
/ Endocrine therapy
/ Epidermal growth factor
/ ErbB-2 protein
/ Estrogen Antagonists - therapeutic use
/ Estrogen receptors
/ Female
/ Humans
/ Kaplan-Meier Estimate
/ Klinisk medicin
/ Lymphatic Metastasis
/ Lymphatic system
/ Medical and Health Sciences
/ Medical research
/ Medicin och hälsovetenskap
/ Middle Aged
/ Monoclonal antibodies
/ Neoplasm Grading
/ Neoplasm Metastasis
/ Neoplasm Recurrence, Local
/ Patients
/ Progesterone
/ Prognosis
/ Proportional Hazards Models
/ Receptors, Estrogen
/ Recurrence
/ Risk
/ Systematic review
/ Targeted cancer therapy
/ Trastuzumab
/ Womens health
2017
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
by
Dowsett, Mitch
, Hayes, Daniel F
, Braybrooke, Jeremy
, Pritchard, Kathleen I
, Bergh, Jonas
, Davies, Christina
, Gray, Richard
, Peto, Richard
, McGale, Paul
, Pan, Hongchao
, Taylor, Carolyn
in
Adult
/ Age
/ Aged
/ Breast cancer
/ Breast Neoplasms - drug therapy
/ Breast Neoplasms - mortality
/ Breast Neoplasms - pathology
/ Cancer and Oncology
/ Cancer och onkologi
/ Chemotherapy, Adjuvant
/ Clinical Medicine
/ Clinical outcomes
/ Clinical trials
/ Drug Administration Schedule
/ Endocrine therapy
/ Epidermal growth factor
/ ErbB-2 protein
/ Estrogen Antagonists - therapeutic use
/ Estrogen receptors
/ Female
/ Humans
/ Kaplan-Meier Estimate
/ Klinisk medicin
/ Lymphatic Metastasis
/ Lymphatic system
/ Medical and Health Sciences
/ Medical research
/ Medicin och hälsovetenskap
/ Middle Aged
/ Monoclonal antibodies
/ Neoplasm Grading
/ Neoplasm Metastasis
/ Neoplasm Recurrence, Local
/ Patients
/ Progesterone
/ Prognosis
/ Proportional Hazards Models
/ Receptors, Estrogen
/ Recurrence
/ Risk
/ Systematic review
/ Targeted cancer therapy
/ Trastuzumab
/ Womens health
2017
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Journal Article
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
2017
Request Book From Autostore
and Choose the Collection Method
Overview
In a meta-analysis of 88 trials involving nearly 63,000 women with breast cancer who were disease-free after 5 years of endocrine therapy, the risk of recurrence ranged from 10 to 41% between years 5 and 20, depending on nodal status and tumor grade.
Publisher
Massachusetts Medical Society
This website uses cookies to ensure you get the best experience on our website.